Hikma Pharmaceutical | HIK - Ebitda


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Hikma Pharmaceutical

Hikma Pharmaceutical reported $350M in EBITDA for its fiscal semester ending in December of 2022.


Ebitda Change
Almirall SA ALM:SM EUR 77.96M 19.34M
AstraZeneca AZN:LN USD 4.28B 965M
Bayer BAYN:GR EUR 4.47B 1.31B
Fresenius FRE:GR EUR 1.61B 509M
GlaxoSmithKline GSK:LN GBP 2.56B 960M
Hikma Pharmaceutical HIK:LN USD 350M 1000K
Lonza Group LONN:SW CHF 1.21B 220M
Orion ORNBV:FH EUR 67.7M 14.6M
Recordati REC:IM EUR 212.55M 72.5M
Roche Holding ROG:VX 10.43B 3B
UCB UCB:BB 451M 363M